Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vernalis teams up with Servier again in third cancer collaboration

Executive Summary

Vernalis PLC and Servier SA are teaming up for the third time in another three-year collaboration that again uses Vernalis’ fragment and structure-based platform to discover drugs for an undisclosed oncology target. Vernalis will receive milestone payments as well as royalties on sales if a resulting product is commercialized.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies